These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6280300)

  • 1. [A comparative study of alizapride and metopimazine (author's transl)].
    Casanova P; Girard D
    Sem Hop; 1982 Feb; 58(6):345-8. PubMed ID: 6280300
    [No Abstract]   [Full Text] [Related]  

  • 2. [A study of the antiemetic effect of alizapride (author's transl)].
    Casanova P
    Sem Hop; 1982 Feb; 58(6):367-70. PubMed ID: 6280305
    [No Abstract]   [Full Text] [Related]  

  • 3. [A study of alizapride, a new benzamide, in nausea and emesis in internal medicine (author's transl)].
    Girard D; Salles E; Bel A
    Sem Hop; 1982 Feb; 58(6):353-6. PubMed ID: 6280302
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of vomiting in infants and children induced by acute infectious pathology. A comparative study of alizapride versus metopimazine].
    Debray H; Guihard J; Peyramond D; Tron P
    Ann Pediatr (Paris); 1990 Dec; 37(10):683-7. PubMed ID: 2291597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A double-blind study of alizapride in nausea and emesis induced by cancer chemotherapeutic agents (author's transl)].
    Viala JJ; Girard D; Cordier JF
    Sem Hop; 1982 Feb; 58(6):371-4. PubMed ID: 6280306
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness of alizapride against emesis in infants and children (author's transl)].
    Carcassonne M
    Sem Hop; 1982 Feb; 58(6):357-61. PubMed ID: 6280303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A double-blind crossover trial of alizapride versus placebo regarding effectiveness against nausea and emesis induced by cancer chemotherapeutic agents (author's transl)].
    Pommatau E
    Sem Hop; 1982 Feb; 58(6):363-6. PubMed ID: 6280304
    [No Abstract]   [Full Text] [Related]  

  • 8. [Alizapride in a double-blind trial with metoclopramide in nausea and vomiting caused by radiotherapy].
    Budach V; Krüger K
    Fortschr Med; 1983 Oct; 101(39):1792-4. PubMed ID: 6642386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of a new antiemetic, alizapride, in cancerology (author's transl)].
    Cupissol D; Favier F; Favier C; Serrou B
    Sem Hop; 1982 Jun; 58(22):1370-3. PubMed ID: 6287597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Manometric effects of metopimazine on the lower esophageal sphincter (author's transl)].
    Gosselin A; Gosselin M; Bretagne JF
    Sem Hop; 1981 Feb 8-15; 57(5-6):291-5. PubMed ID: 6259751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative statistical study of two antiemetics, metoclopramide and metopimazine, effects on the oestrus cycle in the female rat (author's transl)].
    Jadot G; Bruguerolle B; Bouyard L; Fabregou-Bergier P; Bouyard P
    Pathol Biol (Paris); 1980 Jan; 28(1):68-72. PubMed ID: 6987597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Double blind randomized trial of metopimazine: for postoperative nausea and vomiting after cholecystectomy].
    Rodary C; Elman A; Durand M; Cohen-Solal J; Maillard JN
    Ann Anesthesiol Fr; 1979; 20(2):118-20. PubMed ID: 38705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of the effectiveness of alizapride against emesis in children (author's transl)].
    Battistelli F; Lestradet H
    Sem Hop; 1982 Feb; 58(6):349-52. PubMed ID: 6280301
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic value of metopimazine as an antiemetic in cancerology].
    Guerin MT; Guerin RA; Salaün O
    Presse Med (1893); 1969 May; 77(24):893. PubMed ID: 5797645
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose alizapride versus high-dose domperidone: a double-blind comparative study in the management of cis-platinum-induced emesis.
    Huys J; Troch M; Bourguignon RP; Smets P
    Curr Med Res Opin; 1985; 9(6):400-6. PubMed ID: 3886305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative double-blind study: alizapride-metoclopramide].
    Oberling F
    Ann Gastroenterol Hepatol (Paris); 1984; 20(1):59-61. PubMed ID: 6529162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled studies of metopimazine for the treatment of nausea and vomiting.
    Moertel CG; Reitemeier RJ
    J Clin Pharmacol; 1973 Jul; 13(7):283-7. PubMed ID: 4576417
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
    Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P
    Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation sickness--a new approach to management.
    McNab D
    Radiography; 1978 Oct; 44(526):239-40. PubMed ID: 364527
    [No Abstract]   [Full Text] [Related]  

  • 20. Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy.
    Sigsgaard T; Herrstedt J; Andersen LJ; Havsteen H; Langer SW; Kjaerbøl AG; Lund H; Kjaer M; Dombernowsky P
    Br J Cancer; 1999 May; 80(3-4):412-8. PubMed ID: 10408847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.